DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Ralevic V, Burnstock G. Receptors for purines and pyrimidines.
Pharm Rev, 1998, 50:413–492.
Ramsey IS, Delling M, Clapham DE. An introduction to TRP
channels. Annu Rev Physiol, 2006, 68:619–647.
Robas N, O’Reilly M, Katugampola S, Fidock M. Maximizing
serendipity: strategies for identifying ligands for orphan
G- protein- coupled receptors. Curr Opin Pharmacol, 2003,
3:121–126.
Robertson SJ, Ennion SJ, Evans RJ, Edwards FA. Synaptic P2X
receptors. Curr Opin Neurobiol, 2001, 11:378–386.
Shepherd GM. The Synaptic Organization of the Brain. Oxford
University Press, New York, 2003.
Siegel GJ, Albers RW, Brady ST, Price DL. Basic
Neurochemistry: Molecular, Cellular and Medical Aspects.
Elsevier, San Diego, 2006.
Sola M, Bavro VN, Timmins J, et al. Structural basis of dynamic
glycine receptor clustering by gephyrin. EMBO J, 2004,
23:2510–2519.
Thurmond RL, Desai PJ, Dunford PJ, et al. A potent and selective
histamine H 4
receptor antagonist with antiinflammatory
properties. J Pharmacol Exp Ther, 2004, 309:404–413.
Unwin N. Nicotinic acetylcholine receptor at 9Å resolution. J
Mol Biol, 1993, 229:1101–1124.
Violin JD, Lefkowitz RJ. β- Arrestin- biased ligands at seventransmembrane
receptors. Trends Pharm Sci, 2007, 28;
416–422.
Wang J, Asensio VC, Campbell IL. Cytokines and chemokines
as mediators of protection and injury in the central nervous
system assessed in transgenic mice. Curr Top Microbiol
Immunol, 2002, 265:23–48.
Yu FH, Yarov-Yarovoy V, Gutman GA, Catterall WA. Overview
of molecular relationships in the voltage-gated ion channel
superfamily. Pharmacol Rev, 2005, 57:387–395.
395
CHAPTER 14
NEUROTRANSMISSION AND THE CENTRAL NERVOUS SYSTEM